Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 50 (RPL21P50)

Target
RPL21P50
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L21 pseudogene 50 (RPL21P50) is a processed pseudogene located in the human genome. It is one of the many pseudogenes that share high sequence similarity with the functional ribosomal protein L21 gene but does not code for a functional protein product. Pseudogenes like RPL21P50 often result from gene duplication or retrotransposition events and typically lack functional biological roles. They are not used as therapeutic targets and do not encode receptors, enzymes, or other protein products relevant for drug development[9][10][11]. Key clarifications: - RPL21P50 is a pseudogene, not a coding gene or recognized drug target; thus, it is not involved in known molecular, cellular, or disease pathways. - There is no evidence or record that RPL21P50 produces a functional protein, is implicated in disease, or is actionable by drugs. - If you are interested in the functional ribosomal protein, refer to the gene RPL21 (ribosomal protein L21), which is a bona fide protein-coding gene crucial for ribosome function[1][2][5][12]. RPL21 itself has been linked to disorders such as hereditary hypotrichosis simplex[1][5], but RPL21P50 is not. If you need information on the functional protein (RPL21), that should be queried separately using its canonical gene symbol.

Other names
RPL21_18_516RPL21P50

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 50 (RPL21P50).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 50 (RPL21P50).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call